OpenAI Gains Early Lead in AI IPO Race Amid Confidential Filing Reports
Morgan Stanley Lowers Polaris PII Price Target to 69 Amid Rate and Tariff Concerns
Kevin Warshs Potential Fed Overhaul Could Reshape Wall Streets Market Plumbing
Despite Regulatory Uncertainty Prediction Market Firms Push Forward with Expansion Plans
Amazoncom Inc Why Wall Street Continues to Focus on the ECommerce Giant
Jim Cramer Expresses Optimism on Palo Alto Networks Amid Broad Cybersecurity Demand
Power REIT PW Q2 2025 Earnings Positive EPS of 012 Drives Stock Higher
NWBI Q1 2026 Earnings EPS Surges Past Estimates with 1472 Beat
IBEX Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
KMPB Q1 2026 Earnings Significant Earnings Miss Raises Concerns for FixedRate Reset Debentures
MSGS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Positive Stock Reaction
FINV Q1 2026 Earnings EPS of 1764126 Drives Stock Surge Despite Missing Revenue Context
Xerox Holdings Warrants XRXDW Jump 13 as Speculative Momentum Builds
ARMOUR Residential REIT Inc ARR Slides Slightly Tests Key Support Levels Amid Sector Pressure
Damora Therapeutics Holds Steady Near Key Support Amid Quiet Trading
LendingClub Stock Edges Lower as Shares Test Key Technical Levels
Seaboard Corporation SEB Holds Steady Near 4900 Amidst Sector Uncertainty
Wipro Announces 15000 Crore Share Buyback Record Date Set for June 5 2026
Tao Synergies Inc TAOX Q4 2024 Earnings EPS Misses Estimates as Shares Slide
Aptorum Group APM Dips 246 as Stock Approaches Critical Support Level
US MA Regulatory Landscape in 2026 Antitrust CFIUS and Disclosure Rules
South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest
Custard Apple Market Expansion Faces Export Hurdles Despite Fruits Growing Popularity
Petraeus Suggests Iran May Concede on Strait of Hormuz in Potential Peace Deal
Mphasis and Glenmark Among Jay Thakkars ShortTerm FO Picks Amid Market Caution
ColgatePalmolive India Shifts Focus to Premium Oral Care and Digital Execution for Growth
Viatris Inc Analysts Weigh PostMerger Strategy and Generic Drug Portfolio Outlook